Cart
sales@molnova.com
UCB-5307
CAS No. 1515887-44-1
UCB-5307( —— )
Catalog No. M35511 CAS No. 1515887-44-1
UCB-5307 is a small molecule compound that inhibits TNFR1 signal transduction and downstream function in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 116 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 428 | In Stock |
|
| 50MG | 617 | In Stock |
|
| 100MG | 879 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1748 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUCB-5307
-
NoteResearch use only, not for human use.
-
Brief DescriptionUCB-5307 is a small molecule compound that inhibits TNFR1 signal transduction and downstream function in vitro.
-
DescriptionUCB-5307 is a potent TNF signaling inhibitor with a KD of 9 nM for human TNFα. UCB-5307 can penetrate the preformed hTNF/hTNFR1 complex.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetTNF
-
RecptorTNF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1515887-44-1
-
Formula Weight343.42
-
Molecular FormulaC22H21N3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (145.59 mM; Ultrasonic )
-
SMILESCc1ccc(C)c(Cn2c(nc3ccccc23)C(O)c2ccncc2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. O'Connell J, et al. Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer. Nat Commun. 2019 Dec 19;10(1):5795.?
molnova catalog
related products
-
7β-O-Methylmorronisi...
7β-O-Methylmorroniside (7R-O-methylmorroniside) is a R-isomer of 7-O-Methyl morroniside.
-
Secoisolariciresinol
Secoisolariciresinol is an enterolignan precursor, it has antioxidant, and estrogen-like activities, it can significantly suppress triglyceride (TG) accumulation in 3T3-L1 adipocytes.
-
α-Humulene
α-Humulene is extracted from S.officinalis essential oil.α-Humulene can inhibit tumor cell growth.α-Humulene also shows anti-inflammatory effects, probably by interfering with TNFalpha production and COX-2 and iNOS expression.
